Advertisement
ข่าวฟอเร็กซ์
Enveric Biosciences Plans About 35 Percent Reduction In Full-time Personnel
Biotechnology company Enveric Biosciences, Inc. (ENVB) announced Monday a cost reduction plan resulting in approximately 40% to 55% decrease in expenses and extension of financial runway into the first quarter of 2024.
RTTNews |
825 วันที่ผ่านมา
Euro, Pound Advance On Progress In Debt Ceiling Talks
The euro and the pound firmed against their major counterparts in the European session on Monday, as U.S. debt ceiling jitters eased following President Joe Biden's remarks that he is hopeful of reaching a deal to raise the borrowing limit.
RTTNews
|
825 วันที่ผ่านมา
Allergan Aesthetics Says FDA Approves SKINVIVE By JUVEDERM
Allergan Aesthetics, an AbbVie company (ABBV), announced Monday the U.S. FDA approval of SKINVIVE by JUVEDERM to improve skin smoothness of the cheeks in adults over the age of 21.
RTTNews
|
825 วันที่ผ่านมา
New York Manufacturing Index Plunges Much More Than Expected In May
New York manufacturing activity has seen a substantial downturn in the month of May, according to a report released by the Federal Reserve Bank of New York on Monday.
RTTNews
|
825 วันที่ผ่านมา
Eurozone Industrial Production Falls Most In 17 Months
Eurozone industrial production declined at the fastest pace in nearly one-and-and-a-half years in March, largely led by a slump in the capital goods output, and suggested that a downward revision to the first quarter economic growth was likely.
RTTNews
|
825 วันที่ผ่านมา
Bay Street Likely To Open Slightly Higher
Canadian shares are likely to open with a positive bias on Monday, tracking higher crude oil prices and steady European markets.
RTTNews
|
825 วันที่ผ่านมา
UniQure To Sell Royalty Interest In HEMGENIX For Up To $400 Mln
Gene therapy company uniQure N.V. (QURE) announced Monday it has entered into a definitive agreement to sell a portion of the royalty rights due to uniQure from CSL Behring from the net sales of HEMGENIX (etranacogene dezaparvovec-drbl) to HealthCare Royalty (HCRx) and Sagard Healthcare for a gross purchase price of up to $400 million in cash.
RTTNews
|
825 วันที่ผ่านมา
more news
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
825 วันที่ผ่านมา
Venator Materials Reaches Comprehensive Agreement To Chapter 11 Bankruptcy
Venator Materials PLC (VNTR) announced Monday that it has reached an agreement with the overwhelming majority of its lenders and noteholders on the terms of a comprehensive recapitalization plan.
RTTNews
|
825 วันที่ผ่านมา
Sensex Rises Over 300 Points; Nifty Nears 18,400
Indian shares advanced on Monday as Tata Motors and DLF reported strong earnings and data showed India's wholesale price inflation declined for an eleventh straight month to turn negative in April.
RTTNews
|
825 วันที่ผ่านมา
European Shares Gain On Optimism About EU's Growth Outlook
European stocks rose on Monday as investors assessed the results of Turkey's presidential election and looked for progress in talks on the U.S. debt ceiling.
RTTNews
|
825 วันที่ผ่านมา
FTSE 100 Gains Led By Mining Stocks
U.K. stocks were moving higher on Monday despite lingering worries about slowing global growth.
RTTNews
|
825 วันที่ผ่านมา
Thailand GDP Growth Exceeds Expectations In Q1
The Thai economy registered a faster-than-expected growth in the first quarter underpinned by exports, household spending and investment. Gross domestic product posted an annual growth of 2.7 percent after expanding 1.4 percent in the preceding quarter, the Office of the National Economic and Social Development Council reported Monday. GDP was expected to grow 2.3 percent.
RTTNews
|
825 วันที่ผ่านมา
Stay up to date!
Add ข่าว to your browser
Add To Chrome
